Siren Raises $9.5M, Led by an $8M Investment from Mölnlycke Health Care to Drive Diabetic Foot Ulcer Prevention and Management

Siren announces investment by Mölnlycke of $8 million to further development and adoption of Siren’s innovative diabetic foot ulcer prevention solution.